<DOC>
	<DOCNO>NCT02447250</DOCNO>
	<brief_summary>The purpose study help determine best dose albuterol premature baby risk develop bronchopulmonary dysplasia ( BPD ) . BPD chronic lung disease prematurity associate increased morbidity mortality , long hospital stay , increase healthcare utilization . Albuterol inhaled medication frequently use premature infant chronic lung disease people asthma . It believe safe , optimal dose infant clear . The investigator hypothesize albuterol may help subset premature infant lung disease , need determine best dose prior research effective chronic lung disease/BPD . Response three dos albuterol measure use pulmonary function test .</brief_summary>
	<brief_title>Preterm Infant Inhaled Albuterol Dosing</brief_title>
	<detailed_description>1 . Recruitment : Subjects risk develop bronchopulmonary dysplasia recruit Doernbecher Neonatal Care Center ( DNCC ) .The subject ' mother approach investigator consent obtain agree participate . 2 . Medical Record Interview : Information pregnancy , delivery , neonatal course obtain medical record . This include maternal body mass index ( BMI ) first prenatal visit , maternal age parity , birthweight , gestational age birth , history maternal betamethasone fetal lung maturation , indication preterm delivery ( e.g . pre-eclampsia , preterm labor ) , surfactant administration , history intubation duration mechanical ventilation infant , current level respiratory support , use diuretic , bronchodilator , corticosteroid neonate . A brief interview also obtain subject 's mother . The question ask involve tobacco exposure pregnancy family history asthma . The purpose data collect infant 's mother help identify factor may predict premature infant respond albuterol . 3 . Procedures : Pulmonary function test ( PFTs ) procedures involve study . PFTs non-invasive , require sedation , commonly use provide standard medical care preterm infant DNCC . PFTs involve place mask nose mouth quiet sleep . We record flow-volume loop passive respiration measure respiratory compliance passive respiratory resistance ( Rr ) use single breath occlusion technique . A dose albuterol give baseline measurement obtain ; PFTs repeat 15 minute administration . The test three session , except dose albuterol alter session ( see ) . There one session per day , three session occur within 7 day period . Vital sign ( respiratory rate , heart rate , oxygen saturation ) continuously monitor test . 4 . Study Drug : Albuterol bronchodilator frequently prescribe neonatal ICUs help treat symptom BPD . About 50 % preterm infant DNCC evolve BPD show improvement PFT 2 puff ( 180 microgram ) albuterol ( unpublished data ) . The typical dose 2-4 puff every 4-6 hour optimal dose premature infant know . In study , 2 puff give first day PFTs , 3 puff second day , 4 puff third day .</detailed_description>
	<mesh_term>Birth Weight</mesh_term>
	<mesh_term>Bronchopulmonary Dysplasia</mesh_term>
	<mesh_term>Albuterol</mesh_term>
	<criteria>low birthweight infant ( &lt; 1500g ) gestational age &lt; 32 week age 1428 day continue require respiratory support and/or supplemental oxygen chromosomal abnormality major congenital anomaly congenital heart disease , except atrial septal defect patent ductus arteriosus clinical provider determine subject unstable undergo pulmonary function test</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>28 Days</maximum_age>
	<verification_date>October 2013</verification_date>
	<keyword>Bronchopulmonary dysplasia</keyword>
	<keyword>low birth weight</keyword>
	<keyword>albuterol</keyword>
	<keyword>pulmonary function test</keyword>
</DOC>